{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:47:32Z","timestamp":1779245252050,"version":"3.51.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_122419"],"award-info":[{"award-number":["320030_122419"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_122419"],"award-info":[{"award-number":["320030_122419"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Center of Competence in Research(NCCR)\u201cSYNAPSY The Synaptic Bases of Mental Diseases\u201d,"},{"name":"Grant of the Adrian and Simone Frutiger Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In view of its heterogeneity, schizophrenia needs new diagnostic tools based on mechanistic biomarkers that would allow early detection. Complex interaction between genetic and environmental risk factors may lead to NMDAR hypofunction, inflammation and redox dysregulation, all converging on oxidative stress. Using computational analysis, the expression of 76 genes linked to these systems, known to be abnormally regulated in schizophrenia, was studied in skin-fibroblasts from early psychosis patients and age-matched controls (<jats:italic>N<\/jats:italic>\u2009=\u200930), under additional pro-oxidant challenge to mimic environmental stress. To evaluate the contribution of a genetic risk related to redox dysregulation, we investigated the GAG trinucleotide polymorphism in the key glutathione (GSH) synthesizing enzyme, glutamate-cysteine-ligase-catalytic-subunit (<jats:italic>gclc<\/jats:italic>) gene, known to be associated with the disease. Patients and controls showed different gene expression profiles that were modulated by GAG-<jats:italic>gclc<\/jats:italic> genotypes in combination with oxidative challenge. In GAG-<jats:italic>gclc<\/jats:italic> low-risk genotype patients, a global gene expression dysregulation was observed, especially in the antioxidant system, potentially induced by other risks. Both controls and patients with GAG-<jats:italic>gclc<\/jats:italic> high-risk genotype (<jats:italic>gclc<\/jats:italic>GAG-HR) showed similar gene expression profiles. However, under oxidative challenge, a boosting of other antioxidant defense, including the master regulator Nrf2 and TRX systems was observed only in <jats:italic>gclc<\/jats:italic>GAG-HR controls, suggesting a protective compensation against the genetic GSH dysregulation. Moreover, RAGE (redox\/inflammation interaction) and AGMAT (arginine pathway) were increased in the <jats:italic>gclc<\/jats:italic>GAG-HR patients, suggesting some additional risk factors interacting with this genotype. Finally, the use of a machine-learning approach allowed discriminating patients and controls with an accuracy up to 100%, paving the way towards early detection of schizophrenia.<\/jats:p>","DOI":"10.1038\/s41380-023-02034-x","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T10:03:31Z","timestamp":1680257011000},"page":"1983-1994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1327-535X","authenticated-orcid":false,"given":"Basilio","family":"Giangreco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-9007","authenticated-orcid":false,"given":"Daniella","family":"Dwir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Klauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6479-5381","authenticated-orcid":false,"given":"Raoul","family":"Jenni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2273-6241","authenticated-orcid":false,"given":"Philippe","family":"Golay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Cleusix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp S.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Cu\u00e9nod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Conus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Toni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1968-1646","authenticated-orcid":false,"given":"Kim Q.","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"2034_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-015-0562-2","volume":"15","author":"KR Laurens","year":"2015","unstructured":"Laurens KR, Luo L, Matheson SL, Carr VJ, Raudino A, Harris F, et al. Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses. BMC Psychiatry. 2015;15:9.","journal-title":"BMC Psychiatry"},{"key":"2034_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1176\/appi.ajp.2008.08010089","volume":"166","author":"AS Brown","year":"2009","unstructured":"Brown AS, Vinogradov S, Kremen WS, Poole JH, Deicken RF, Penner JD, et al. Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry. 2009;166:683\u201390.","journal-title":"Am J Psychiatry"},{"key":"2034_CR3","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1017\/S0033291720002421","volume":"50","author":"L Alameda","year":"2020","unstructured":"Alameda L, Rodriguez V, Carr E, Aas M, Trotta G, Marino P, et al. A systematic review on mediators between adversity and psychosis: potential targets for treatment. Psychol Med. 2020;50:1966\u201376.","journal-title":"Psychol Med"},{"key":"2034_CR4","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/mp.2017.47","volume":"22","author":"P Steullet","year":"2017","unstructured":"Steullet P, Cabungcal JH, Coyle J, Didriksen M, Gill K, Grace AA, et al. Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia. Mol Psychiatry. 2017;22:936\u201343.","journal-title":"Mol Psychiatry"},{"key":"2034_CR5","doi-asserted-by":"publisher","first-page":"12495","DOI":"10.1073\/pnas.1812821115","volume":"115","author":"L Alameda","year":"2018","unstructured":"Alameda L, Fournier M, Khadimallah I, Griffa A, Cleusix M, Jenni R, et al. Redox dysregulation as a link between childhood trauma and psychopathological and neurocognitive profile in patients with early psychosis. Proc Natl Acad Sci USA 2018;115:12495\u2013500.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2034_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pnpbp.2011.11.003","volume":"42","author":"U Meyer","year":"2013","unstructured":"Meyer U. Developmental neuroinflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2013;42:20\u201334.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2034_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Consortium SWG of the PG.","year":"2014","unstructured":"Consortium SWG of the PG. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature"},{"key":"2034_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neures.2013.10.009","volume":"79","author":"D Mehta","year":"2014","unstructured":"Mehta D, Iwamoto K, Ueda J, Bundo M, Adati N, Kojima T, et al. Comprehensive survey of CNVs influencing gene expression in the human brain and its implications for pathophysiology. Neurosci Res 2014;79:22\u201333.","journal-title":"Neurosci Res"},{"key":"2034_CR9","doi-asserted-by":"publisher","first-page":"16621","DOI":"10.1073\/pnas.0706778104","volume":"104","author":"R Gysin","year":"2007","unstructured":"Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, et al. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci USA 2007;104:16621\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2034_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","volume":"19","author":"KQ Do","year":"2009","unstructured":"Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol. 2009;19:220\u201330.","journal-title":"Curr Opin Neurobiol"},{"key":"2034_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/schbul\/sbw038","volume":"42","author":"L Xin","year":"2016","unstructured":"Xin L, Mekle R, Fournier M, Baumann PS, Ferrari C, Alameda L, et al. Genetic polymorphism associated prefrontal glutathione and its coupling with brain glutamate and peripheral redox status in early psychosis. Schizophr Bull 2016;42:1185\u201396.","journal-title":"Schizophr Bull"},{"key":"2034_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/schbul\/sbu053","volume":"40","author":"M Fournier","year":"2014","unstructured":"Fournier M, Ferrari C, Baumann PS, Polari A, Monin A, Bellier-Teichmann T, et al. Impaired metabolic reactivity to oxidative stress in early psychosis patients. Schizophr Bull. 2014;40:973\u201383.","journal-title":"Schizophr Bull"},{"key":"2034_CR13","doi-asserted-by":"publisher","first-page":"13422","DOI":"10.1074\/jbc.271.23.13422","volume":"271","author":"R Pinkus","year":"1996","unstructured":"Pinkus R, Weiner LM, Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-\u03baB, and glutathione S-transferase gene expression. J Biol Chem. 1996;271:13422\u20139.","journal-title":"J Biol Chem"},{"key":"2034_CR14","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1073\/pnas.90.7.2965","volume":"90","author":"T Prestera","year":"1993","unstructured":"Prestera T, Holtzclaw WD, Zhang Y, Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA. 1993;90:2965\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2034_CR15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41380-018-0104-7","volume":"25","author":"J Kumar","year":"2020","unstructured":"Kumar J, Liddle EB, Fernandes CC, Palaniyappan L, Hall EL, Robson SE, et al. Glutathione and glutamate in schizophrenia: a 7T MRS study. Mol Psychiatry. 2020;25:873\u201382.","journal-title":"Mol Psychiatry"},{"key":"2034_CR16","doi-asserted-by":"crossref","unstructured":"Hardingham GE, Do KQ. Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nat Rev Neurosci. 2016:17:125\u201334.","DOI":"10.1038\/nrn.2015.19"},{"key":"2034_CR17","doi-asserted-by":"publisher","first-page":"7266","DOI":"10.3390\/molecules15107266","volume":"15","author":"K-A Jung","year":"2010","unstructured":"Jung K-A, Kwak M-K. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010;15:7266\u201391.","journal-title":"Molecules."},{"key":"2034_CR18","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1074\/jbc.R900010200","volume":"284","author":"T Nguyen","year":"2009","unstructured":"Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem. 2009;284:13291\u20135.","journal-title":"J Biol Chem"},{"key":"2034_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/schbul\/sbs052","volume":"38","author":"EM Sullivan","year":"2012","unstructured":"Sullivan EM, O\u2019Donnell P. Inhibitory interneurons, oxidative stress, and schizophrenia. Schizophr Bull. 2012;38:373\u20136.","journal-title":"Schizophr Bull"},{"key":"2034_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/eip.12037","volume":"7","author":"PS Baumann","year":"2013","unstructured":"Baumann PS, Crespi S, Marion-Veyron R, Solida A, Thonney J, Favrod J, et al. Treatment and early intervention in psychosis program (TIPP-Lausanne): implementation of an early intervention programme for psychosis in Switzerland. Early Interv Psychiatry. 2013;7:322\u20138.","journal-title":"Early Interv Psychiatry"},{"key":"2034_CR21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","volume":"39","author":"A Yung","year":"2005","unstructured":"Yung A, Yung AR, Yuen HP, Mcgorry PD, Phillips LJ, Kelly D, et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry. 2005;39:964\u201371.","journal-title":"Aust N Z J Psychiatry"},{"key":"2034_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF02310792","volume":"35","author":"CB Crawford","year":"1970","unstructured":"Crawford CB, Ferguson GA. A general rotation criterion and its use in orthogonal rotation. Psychometrika. 1970;35:321\u201332.","journal-title":"Psychometrika."},{"key":"2034_CR23","doi-asserted-by":"publisher","first-page":"21592","DOI":"10.1074\/jbc.M300931200","volume":"278","author":"M McMahon","year":"2003","unstructured":"McMahon M, Itoh K, Yamamoto M, Hayes JD. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem. 2003;278:21592\u2013600.","journal-title":"J Biol Chem"},{"key":"2034_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1465-9921-13-92","volume":"13","author":"J Fourtounis","year":"2012","unstructured":"Fourtounis J, Wang I-M, Mathieu M-C, Claveau D, Loo T, Jackson AL, et al. Gene expression profiling following NRF2 and KEAP1 siRNA knockdown in human lung fibroblasts identifies CCL11\/Eotaxin-1 as a novel NRF2 regulated gene. Respir Res. 2012;13:92\u201314.","journal-title":"Respir Res"},{"key":"2034_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0492-8","volume":"9","author":"TA Lanz","year":"2019","unstructured":"Lanz TA, Reinhart V, Sheehan MJ, Rizzo SJS, Bove SE, James LC, et al. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder. Transl Psychiatry. 2019;9:151.","journal-title":"Transl Psychiatry"},{"key":"2034_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.biopsych.2013.01.001","volume":"73","author":"AM Fineberg","year":"2013","unstructured":"Fineberg AM, Ellman LM. Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry. 2013;73:951\u201366.","journal-title":"Biol Psychiatry"},{"key":"2034_CR27","doi-asserted-by":"crossref","unstructured":"Patrick A. Baeuerle and Thomas Henkel; Function and activation of NF-kB in the immune system. Annu Rev Immunol. 1994;12:141\u201379.","DOI":"10.1146\/annurev.iy.12.040194.001041"},{"key":"2034_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/cancers2020483","volume":"2","author":"I Bellezza","year":"2010","unstructured":"Bellezza I, Mierla AL, Minelli A. Nrf2 and NF-\u03baB and their concerted modulation in cancer pathogenesis and progression. Cancers. 2010;2:483\u201397.","journal-title":"Cancers."},{"key":"2034_CR29","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/sj.onc.1206198","volume":"22","author":"K Hinata","year":"2003","unstructured":"Hinata K, Gervin AM, Zhang YJ, Khavari PA. Divergent gene regulation and growth effects by NF-kappa B in epithelial and mesenchymal cells of human skin. Oncogene. 2003;22:1955\u201364.","journal-title":"Oncogene."},{"key":"2034_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.biopsych.2008.10.018","volume":"65","author":"X-Q Song","year":"2009","unstructured":"Song X-Q, Lv L-X, Li W-Q, Hao Y-H, Zhao J-P. The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biol Psychiatry. 2009;65:481\u20138.","journal-title":"Biol Psychiatry"},{"key":"2034_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","volume":"31","author":"A Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","unstructured":"Jab\u0142o\u0144ska-Trypu\u0107 A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzym Inhib Med Chem. 2016;31:177\u201383.","journal-title":"J Enzym Inhib Med Chem"},{"key":"2034_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00216-016-9900-6","volume":"409","author":"MK Sethi","year":"2017","unstructured":"Sethi MK, Zaia J. Extracellular matrix proteomics in schizophrenia and Alzheimer\u2019s disease. Anal Bioanal Chem. 2017;409:379\u201394.","journal-title":"Anal Bioanal Chem"},{"key":"2034_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, Rivera H, de, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177\u201383.","journal-title":"Nature."},{"key":"2034_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.schres.2018.11.035","volume":"204","author":"L Laskaris","year":"2019","unstructured":"Laskaris L, Zalesky A, Weickert CS, Biase MAD, Chana G, Baune BT, et al. Investigation of peripheral complement factors across stages of psychosis. Schizophr Res. 2019;204:30\u20137.","journal-title":"Schizophr Res"},{"key":"2034_CR35","doi-asserted-by":"publisher","unstructured":"Mongan D, F\u00f6cking M, Healy C, Susai SR, Heurich M, Wynne K, et al. Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence. JAMA Psychiatry. 2020. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.2459.","DOI":"10.1001\/jamapsychiatry.2020.2459"},{"key":"2034_CR36","doi-asserted-by":"publisher","unstructured":"Dwir D, Giangreco B, Xin L, Tenenbaum L, Cabungcal J-H, Steullet P, et al. MMP9\/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory\/excitatory imbalance: a reverse translation study in schizophrenia patients. Nature Publishing Group. 2019. https:\/\/doi.org\/10.1038\/s41380-019-0393-5.","DOI":"10.1038\/s41380-019-0393-5"},{"key":"2034_CR37","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.3390\/nu7031426","volume":"7","author":"KAP Wijnands","year":"2015","unstructured":"Wijnands KAP, Castermans TMR, Hommen MPJ, Meesters DM, Poeze M. Arginine and citrulline and the immune response in sepsis. Nutrients. 2015;7:1426\u201363.","journal-title":"Nutrients."},{"key":"2034_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00726-004-0078-4","volume":"26","author":"J Satriano","year":"2004","unstructured":"Satriano J. Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article. Amino Acids. 2004;26:321\u20139.","journal-title":"Amino Acids"},{"key":"2034_CR39","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1046\/j.0953-816x.2001.01799.x","volume":"14","author":"G Grima","year":"2001","unstructured":"Grima G, Benz B, Do KQ. Glial-derived arginine, the nitric oxide precursor, protects neurons from NMDA-induced excitotoxicity. Eur J Neurosci. 2001;14:1762\u201370.","journal-title":"Eur J Neurosci"},{"key":"2034_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrm3072","volume":"12","author":"JY Altarejos","year":"2011","unstructured":"Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol. 2011;12:141\u201351.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2034_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/jcp.21162","volume":"213","author":"AK Ghosh","year":"2007","unstructured":"Ghosh AK, Varga J. The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J Cell Physiol. 2007;213:663\u201371.","journal-title":"J Cell Physiol"},{"key":"2034_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.nbd.2015.03.011","volume":"77","author":"V Reinhart","year":"2015","unstructured":"Reinhart V, Bove SE, Volfson D, Lewis DA, Kleiman RJ, Lanz TA. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder. Neurobiol Dis. 2015;77:220\u20137.","journal-title":"Neurobiol Dis"},{"key":"2034_CR43","doi-asserted-by":"publisher","first-page":"11088","DOI":"10.1523\/JNEUROSCI.1234-11.2011","volume":"31","author":"TM Hyde","year":"2011","unstructured":"Hyde TM, Lipska BK, Ali T, Mathew SV, Law AJ, Metitiri OE, et al. Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia. J Neurosci. 2011;31:11088\u201395.","journal-title":"J Neurosci"},{"key":"2034_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nn.3890","volume":"18","author":"G Deidda","year":"2014","unstructured":"Deidda G, Allegra M, Cerri C, Naskar S, Bony G, Zunino G, et al. Early depolarizing GABA controls critical-period plasticity in the rat visual cortex. Nat Neurosci. 2014;18:87\u201396.","journal-title":"Nat Neurosci"},{"key":"2034_CR45","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00702-019-02080-2","volume":"126","author":"SJ Kaar","year":"2019","unstructured":"Kaar SJ, Angelescu I, Marques TR, Howes OD. Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies. J Neural Transm. 2019;126:1637\u201351.","journal-title":"J Neural Transm"},{"key":"2034_CR46","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.molcel.2011.11.027","volume":"45","author":"AM Day","year":"2012","unstructured":"Day AM, Brown JD, Taylor SR, Rand JD, Morgan BA, Veal EA. Inactivation of a peroxiredoxin by hydrogen peroxide is critical for thioredoxin-mediated repair of oxidized proteins and cell survival. Mol Cell. 2012;45:398\u2013408.","journal-title":"Mol Cell"},{"key":"2034_CR47","doi-asserted-by":"publisher","first-page":"217580","DOI":"10.1155\/2012\/217580","volume":"2012","author":"H Pan","year":"2012","unstructured":"Pan H, Wang H, Wang X, Zhu L, Mao L. The absence of Nrf2 enhances NF-\u03baB-dependent inflammation following scratch injury in mouse primary cultured astrocytes. Mediators Inflamm. 2012;2012:217580.","journal-title":"Mediators Inflamm"},{"key":"2034_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/mp.2014.162","volume":"20","author":"J Rossier","year":"2014","unstructured":"Rossier J, Bernard A, Cabungcal JH, Perrenoud Q, Savoye A, Gallopin T, et al. Cortical fast-spiking parvalbumin interneurons enwrapped in the perineuronal net express the metallopeptidases Adamts8, Adamts15 and Neprilysin. Mol Psychiatry. 2014;20:154\u201361.","journal-title":"Mol Psychiatry"},{"key":"2034_CR49","doi-asserted-by":"crossref","unstructured":"Vafadari B, Salamian A, Kaczmarek L. MMP-9 in translation: from molecule to brain physiology, pathology and therapy. J Neurochem. 2016;139 Suppl 2:91\u2013114","DOI":"10.1111\/jnc.13415"},{"key":"2034_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neulet.2013.09.059","volume":"556","author":"H Yamamori","year":"2013","unstructured":"Yamamori H, Hashimoto R, Ishima T, Kishi F, Yasuda Y, Ohi K, et al. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine. Neurosci Lett. 2013;556:37\u201341.","journal-title":"Neurosci Lett"},{"key":"2034_CR51","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.1074\/jbc.RA118.002200","volume":"293","author":"KH Sipil\u00e4","year":"2018","unstructured":"Sipil\u00e4 KH, Drushinin K, Rappu P, Jokinen J, Salminen TA, Salo AM, et al. Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms. J Biol Chem. 2018;293:7645\u201358.","journal-title":"J Biol Chem"},{"key":"2034_CR52","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2034_CR53","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.schres.2018.12.015","volume":"206","author":"B Garip","year":"2019","unstructured":"Garip B, Kayir H, Uzun O. l-Arginine metabolism before and after 10 weeks of antipsychotic treatment in first-episode psychotic patients. Schizophr Res. 2019;206:58\u201366.","journal-title":"Schizophr Res"},{"key":"2034_CR54","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1038\/tp.2016.144","volume":"6","author":"P Liu","year":"2016","unstructured":"Liu P, Jing Y, Collie ND, Dean B, Bilkey DK, Zhang H. Altered brain arginine metabolism in schizophrenia. Transl Psychiatry. 2016;6:e871\u2013e871.","journal-title":"Transl Psychiatry"},{"key":"2034_CR55","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jpsychires.2013.04.004","volume":"47","author":"T Uzbay","year":"2013","unstructured":"Uzbay T, Goktalay G, Kayir H, Eker SS, Sarandol A, Oral S, et al. Increased plasma agmatine levels in patients with schizophrenia. J Psychiatr Res. 2013;47:1054\u201360.","journal-title":"J Psychiatr Res"},{"key":"2034_CR56","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11064-018-02712-1","volume":"44","author":"S Barua","year":"2019","unstructured":"Barua S, Kim JY, Kim JY, Kim JH, Lee JE. Therapeutic effect of agmatine on neurological disease: focus on ion channels and receptors. Neurochem Res. 2019;44:735\u201350.","journal-title":"Neurochem Res"},{"key":"2034_CR57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neuroimage.2016.03.075","volume":"145","author":"G Gifford","year":"2017","unstructured":"Gifford G, Crossley N, Fusar-Poli P, Schnack HG, Kahn RS, Koutsouleris N, et al. Using neuroimaging to help predict the onset of psychosis. NeuroImage. 2017;145:209\u201317.","journal-title":"NeuroImage."},{"key":"2034_CR58","doi-asserted-by":"publisher","first-page":"101704","DOI":"10.1016\/j.artmed.2019.101704","volume":"99","author":"AMY Tai","year":"2019","unstructured":"Tai AMY, Albuquerque A, Carmona NE, Subramanieapillai M, Cha DS, Sheko M, et al. Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry. Artif Intell Med. 2019;99:101704.","journal-title":"Artif Intell Med"},{"key":"2034_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev-clinpsy-032816-045037","volume":"14","author":"DB Dwyer","year":"2018","unstructured":"Dwyer DB, Falkai P, Koutsouleris N. Machine learning approaches for clinical psychology and psychiatry. Annu Rev Clin Psychol. 2018;14:91\u2013118.","journal-title":"Annu Rev Clin Psychol"},{"key":"2034_CR60","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2147\/NDT.S202418","volume":"15","author":"R Filippis","year":"2019","unstructured":"Filippis R, de, Carbone EA, Gaetano R, Bruni A, Pugliese V, Segura-Garcia C, et al. Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2019;15:1605\u201327.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2034_CR61","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1007\/s11682-018-9947-4","volume":"13","author":"J Li","year":"2019","unstructured":"Li J, Sun Y, Huang Y, Bezerianos A, Yu R. Machine learning technique reveals intrinsic characteristics of schizophrenia: an alternative method. Brain Imaging Behav. 2019;13:1386\u201396.","journal-title":"Brain Imaging Behav"},{"key":"2034_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12888-018-1678-y","volume":"18","author":"P Mikolas","year":"2018","unstructured":"Mikolas P, Hlinka J, Skoch A, Pitra Z, Frodl T, Spaniel F, et al. Machine learning classification of first-episode schizophrenia spectrum disorders and controls using whole brain white matter fractional anisotropy. BMC Psychiatry. 2018;18:97\u20137.","journal-title":"BMC Psychiatry"},{"key":"2034_CR63","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/schbul\/sbx137","volume":"44","author":"M Rozycki","year":"2018","unstructured":"Rozycki M, Satterthwaite TD, Koutsouleris N, Erus G, Doshi J, Wolf DH, et al. Multisite machine learning analysis provides a robust structural imaging signature of schizophrenia detectable across diverse patient populations and within individuals. Schizophr Bull. 2018;44:1035\u201344.","journal-title":"Schizophr Bull"},{"key":"2034_CR64","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/jamapsychiatry.2018.2165","volume":"75","author":"N Koutsouleris","year":"2018","unstructured":"Koutsouleris N, Kambeitz-Ilankovic L, Ruhrmann S, Rosen M, Ruef A, Dwyer DB, et al. Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: a multimodal, multisite machine learning analysis. JAMA Psychiatry. 2018;75:1156\u201372.","journal-title":"JAMA Psychiatry"},{"key":"2034_CR65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.schres.2019.05.044","volume":"214","author":"A Talpalaru","year":"2019","unstructured":"Talpalaru A, Bhagwat N, Devenyi GA, Lepage M, Chakravarty MM. Identifying schizophrenia subgroups using clustering and supervised learning. Schizophr Res. 2019;214:51\u20139.","journal-title":"Schizophr Res"},{"key":"2034_CR66","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.schres.2016.05.007","volume":"176","author":"M Shim","year":"2016","unstructured":"Shim M, Hwang H-J, Kim D-W, Lee S-H, Im C-H. Machine-learning-based diagnosis of schizophrenia using combined sensor-level and source-level EEG features. Schizophr Res. 2016;176:314\u20139.","journal-title":"Schizophr Res"},{"key":"2034_CR67","doi-asserted-by":"crossref","unstructured":"Gardiner EJ, Cairns MJ, Liu B, Beveridge NJ, Carr V, Kelly B, et al. Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. J Psychiatr Res. 2013;47:425\u201337.","DOI":"10.1016\/j.jpsychires.2012.11.007"},{"key":"2034_CR68","doi-asserted-by":"publisher","first-page":"e0116686","DOI":"10.1371\/journal.pone.0116686","volume":"10","author":"N Cattane","year":"2015","unstructured":"Cattane N, Minelli A, Milanesi E, Maj C, Bignotti S, Bortolomasi M, et al. Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood. PLoS ONE. 2015;10:e0116686.","journal-title":"PLoS ONE"},{"key":"2034_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ajmg.b.32638","volume":"180","author":"YJ Trakadis","year":"2019","unstructured":"Trakadis YJ, Sardaar S, Chen A, Fulginiti V, Krishnan A. Machine learning in schizophrenia genomics, a case-control study using 5,090 exomes. Am J Med Genet Part B Neuropsychiatr Genet. 2019;180:103\u201312.","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"key":"2034_CR70","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41598-020-57467-z","volume":"10","author":"M Etemadikhah","year":"2020","unstructured":"Etemadikhah M, Niazi A, Wetterberg L, Feuk L. Transcriptome analysis of fibroblasts from schizophrenia patients reveals differential expression of schizophrenia-related genes. Sci Rep. 2020;10:630\u20139.","journal-title":"Sci Rep"},{"key":"2034_CR71","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jpsychires.2017.08.003","volume":"95","author":"P Gass\u00f3","year":"2017","unstructured":"Gass\u00f3 P, Mas S, Rodr\u00edguez N, Boloc D, Garc\u00eda-Cerro S, Bernardo M, et al. Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-na\u00efve first-episode schizophrenia patients. J Psychiatr Res. 2017;95:91\u2013101.","journal-title":"J Psychiatr Res"},{"key":"2034_CR72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnmol.2018.00073","volume":"11","author":"J Sainz","year":"2018","unstructured":"Sainz J, Prieto C, Ruso-Julve F, Crespo-Facorro B. Blood gene expression profile predicts response to antipsychotics. Front Mol Neurosci. 2018;11:73.","journal-title":"Front Mol Neurosci"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02034-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:06:44Z","timestamp":1697173604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02034-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2034"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02034-x","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}